Evaxion to host r&d day on may 25, 2023

Copenhagen, denmark, may 16, 2023 (globe newswire) -- evaxion biotech a/s (nasdaq: evax) (“evaxion” or the “company”), a clinical-stage biotechnology company specializing in the discovery and development of ai-powered immunotherapies, today announced that it will hold an r&d day at 12:30 p.m cest on may 25, 2023.

EVAX Ratings Summary

EVAX Quant Ranking